Home / Companies / Viking Therapeutics, Inc. / 21 May 2024
Viking Therapeutics, Inc.: meeting of 21 May 2024
Votes reported on Form N-PX, item by item
513 Form N-PX filers reported votes at the Viking Therapeutics, Inc. meeting of 21 May 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 54.9% of reported votes for; 151 filers withheld from or voted against at least one nominee.
691 vote records from 195 filers. 21 of the 193 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
774 vote records from 508 filers. 55 of the 491 filers that marked the item either way voted against management. 17 filers reported this item without a management mark.
2 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
345 vote records from 193 filers. 1 of the 191 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
46 vote records from 29 filers. 0 of the 28 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
649 vote records from 195 filers. 18 of the 193 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Split or no vote | For | For |
| Fidelity | Abstain or withhold * | For | For |
| Dimensional | Abstain or withhold * | For | For |
| State Street and SPDR | For | For | For |
| American Century | Split or no vote | Against * | For |
| Franklin Templeton | For | For | For |
| Invesco | Split or no vote | For | For |
| Equitable | Split or no vote | For | For |
| Charles Schwab | Split or no vote | For | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | Split or no vote | For | For |
| John Hancock and Manulife | Abstain or withhold * | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Split or no vote | For | For |
| PGIM and Prudential | Abstain or withhold * | For | For |
| Jackson National funds | Abstain or withhold * | For | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| First Trust | Split or no vote | For | For |
| Russell Investments | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | Split or no vote | For | For |
| Brighthouse Funds | Split or no vote | For | For |
| Guggenheim and Rydex | Split or no vote | For | For |
| Columbia Threadneedle | Split or no vote | Against * | For |
| BNY Mellon | Split or no vote | Against * | For |
| Principal | Abstain or withhold * | For | For |
| Pacific Life funds | Split or no vote | For | For |
| Global X | Split or no vote | For | For |
| MFS | Split or no vote | For | For |
| AllianceBernstein | Split or no vote | For | For |
| DWS | Split or no vote | For | For |
| Allspring | Split or no vote | For | For |
| MassMutual | Split or no vote | For | For |
| Harbor Funds | For | For | For |
| Virtus | Split or no vote | For | For |
| Macquarie and Delaware Funds | Split or no vote | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | For | For | For |
| Natixis and Loomis Sayles | No report | For | No report |
| Lord Abbett | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Viking Therapeutics, Inc. meeting?
513 Form N-PX filers reported votes at the meeting of 21 May 2024. On say-on-pay, 55 of 491 voted against management (11.2%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Viking Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Viking Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Viking Therapeutics, Inc. with a meeting date within three days of 21 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.